New York · Nonprofit
INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP
INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP (New York) receives grants from 5 organizations whose IRS filings report $62,009 to it, the largest being WILLIAM RAVEIS CHARITABLE FUND INC ($50,000). 2 of them have funded it in more than one year.
- Revenue FY2024
- $374k
- Funders on record
- 5
- Grants received
- $62k
- Net assets
- $312k
What International Thymic Malignancy Interest Group does
Mission
The mission of ITMIG is to promote the advancement of clinical and basic science pertaining to thymic and other mediastinal malignancies and related conditions
As stated on its FY2024 Form 990.
Programs
ITMIG is aligned with the Foundation for Thymic Cancer Research to advance program services through coordination of the executive director. The executive director is responsible for all activities related to the organization and all program services.
$183,000 spent58% of program spendingResearch and related expenses. The ITMIG database is a major resource for studying the characteristics, treatment strategies, and outcomes of patients with thymic malignancies. More than 2000 patients are enrolled. The database is open to all researches and has data transfer agreements with all major institutions.
$75,000 spent24% of program spendingThe 2024 Annual Meeting was held in Yokohama, Japan, in collaboration with the Japan Lung Cancer Society. The abstract book from the meeting is available in MEDIASTINUM.
$55,672 spent18% of program spending
The 3 programs described on its FY2025 Form 990, listed largest first by expense. Program spending in total: $313,672.
The organization over time
Each line starts at 100 in 2021, so what you read is the shape rather than the size: 150 means half as much again as 2021, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2022 to 2023, from $146k to $0 (−100%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
100% of INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP’s revenue is contributions — more reliant on donations than three-quarters of its peers (82% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 0 of the last 4 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Pam Bruce
Executive director
As listed on its FY2025 Form 990.
Who funds it, year by year
2020 → 2023: the base held at 2 funders, grant income fell $5k → $320.
3 of 5 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 18% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP leans on a few funders — its largest provides 81% of grant income and the top three 97%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
98% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP.
Largest funder’s share by year: 2020 98% · 2021 90% · 2022 83% · 2023 70% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP draws 98% of its grant income from funders outside New York, across 2 states in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $11k arriving through sponsors registered in 3 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP runs a healthier operating margin than three-quarters of the 13,754 health nonprofits its size.
this organization peer median middle 50% of peers· 13,754 health nonprofits $100k–$1M, FY2024
Organizations like INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In New York
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
92% of spending goes to programs.
Governance
Public support
100%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Screen this organization
A dated, signed PDF of the compliance screen for INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP?
- INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP (New York) receives grants from 5 organizations whose IRS filings report $62,009 to it, the largest being WILLIAM RAVEIS CHARITABLE FUND INC ($50,000). 2 of them have funded it in more than one year.
- How many funders does INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP have?
- IRS filings report 5 organizations giving $62,009 in grants to INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP, 2 of which have funded it in more than one year.
- Who is the largest funder of INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP?
- WILLIAM RAVEIS CHARITABLE FUND INC is the largest funder on record, with $50,000 in grants. The full list of funders is on this page.
- How can an organization like INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in New York. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds International Thymic Malignancy Interest Group →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2021–2024), and the filings of 5 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing